Skip to main content
Clinical Trials/CTRI/2020/05/025388
CTRI/2020/05/025388Not yet recruitingPhase 2

A Clinical Study of the Effects of Unani Formulation (Joshanda) with Reference to the Standard Control in the Management of Iltihab Tajawif al-Anf Muzmin (Chronic Sinusitis)

Central council for Research in Unani Medicine New Delhi0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed patients of chronic sinusitis of more than 12 weeks duration.
  • -Patients Irrespective of gender.
  • -Patients in the age group of 20-60 years.
  • -SNOT 22 (Sinonasal Obstruction Test) more than 7.
  • -Patients who have agreed to sign the informed consent form and follow up the protocol

Exclusion Criteria

  • -Subjects below the age of 20 years and above the age of 60 years
  • -Atrophic rhinitis.
  • -Deviated Nasal Septum.
  • -Nasal polyps / Nasal growth / Adenoids.
  • -Patients with systemic diseases like diabetes, cardiovascular, impaired renal and hepatic functions, HIV, T.B., COPD.
  • -Patients who refuse to give the written consent for the study.
  • -Pregnancy and lactating women.
  • -Any of them not covered under inclusive criteria

Investigators

Sponsor
Central council for Research in Unani Medicine New Delhi

Similar Trials